Japanese healthcare expenditures have reached an unsustainable level, leading to a variety of government measures to control biopharmaceutical price increases and promote the use of generics. In order to support highly specialized physicians, life science companies will need to develop novel promotional channels to deliver the right information at the right time.
Adapting to the cultural nuances of the Japanese life science industry will likely require companies to develop a go-to-market plan, revamp organizational structures, understand the changing needs of stakeholders and leverage data-driven analytics to understand the market. This special report examines the key factors that are essential to implementing a successful promotional approach in the changing Japanese environment.
Life Sciences & Pharma
COVID-19 Vaccine Manufacturing: Challenges, Solutions and Implications for the Pharma…